Literature DB >> 23707761

Ursolic acid improves domoic acid-induced cognitive deficits in mice.

Dong-mei Wu1, Jun Lu, Yan-qiu Zhang, Yuan-lin Zheng, Bin Hu, Wei Cheng, Zi-feng Zhang, Meng-qiu Li.   

Abstract

Our previous findings suggest that mitochondrial dysfunction is the mechanism underlying cognitive deficits induced by domoic acid (DA). Ursolic acid (UA), a natural triterpenoid compound, possesses many important biological functions. Evidence shows that UA can activate PI3K/Akt signaling and suppress Forkhead box protein O1 (FoxO1) activity. FoxO1 is an important regulator of mitochondrial function. Here we investigate whether FoxO1 is involved in the oxidative stress-induced mitochondrial dysfunction in DA-treated mice and whether UA inhibits DA-induced mitochondrial dysfunction and cognitive deficits through regulating the PI3K/Akt and FoxO1 signaling pathways. Our results showed that FoxO1 knockdown reversed the mitochondrial abnormalities and cognitive deficits induced by DA in mice through decreasing HO-1 expression. Mechanistically, FoxO1 activation was associated with oxidative stress-induced JNK activation and decrease of Akt phosphorylation. Moreover, UA attenuated the mitochondrial dysfunction and cognitive deficits through promoting Akt phosphorylation and FoxO1 nuclear exclusion in the hippocampus of DA-treated mice. LY294002, an inhibitor of PI3K/Akt signaling, significantly decreased Akt phosphorylation in the hippocampus of DA/UA mice, which weakened UA actions. These results suggest that UA could be recommended as a possible candidate for the prevention and therapy of cognitive deficits in excitotoxic brain disorders. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2′7′-dichlorodihydrofluorescein diacetate; 2′7′-dichlorofluorescein; AAV; AP; APR; ATP production rate; Cognitive deficits; DA; DCF; DCFH-DA; DV; Domoic acid; EGFP; ETC; Forkhead box protein O1; FoxO1; FoxO1 knockdown; HO-1; IOD; JNK; ML; MWM; Mitochondrial dysfunction; Morris water maze; OCT; RCR; ROI; ROS; UA; Ursolic acid; adeno-associated viral; anterior-posterior; c-Jun N-terminal kinase; domoic acid; dorsal–ventral; electron transport chain; enhanced green fluorescent protein; heme oxygenase 1; i.c.v; integral optical density; intracerebroventricular; medial–lateral; optimal cutting temperature medium; reactive oxygen species; region of interest; respiratory control ratio; ursolic acid

Mesh:

Substances:

Year:  2013        PMID: 23707761     DOI: 10.1016/j.taap.2013.04.038

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.

Authors:  Ana B Ramos-Hryb; Francis L Pazini; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

2.  Cognitive deficits and anxiety induced by diisononyl phthalate in mice and the neuroprotective effects of melatonin.

Authors:  Ping Ma; Xudong Liu; Jiliang Wu; Biao Yan; Yuchao Zhang; Yu Lu; Yang Wu; Chao Liu; Junhui Guo; Eewa Nanberg; Carl-Gustaf Bornehag; Xu Yang
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

Review 3.  Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases.

Authors:  Manzar Alam; Sabeeha Ali; Sarfraz Ahmed; Abdelbaset Mohamed Elasbali; Mohd Adnan; Asimul Islam; Md Imtaiyaz Hassan; Dharmendra Kumar Yadav
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

Review 4.  Public health risks associated with chronic, low-level domoic acid exposure: A review of the evidence.

Authors:  Rebekah Petroff; Alicia Hendrix; Sara Shum; Kimberly S Grant; Kathi A Lefebvre; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2021-04-28       Impact factor: 12.310

5.  Cognitive deficits and decreased locomotor activity induced by single-walled carbon nanotubes and neuroprotective effects of ascorbic acid.

Authors:  Xudong Liu; Yuchao Zhang; Jinquan Li; Dong Wang; Yang Wu; Yan Li; Zhisong Lu; Samuel C T Yu; Rui Li; Xu Yang
Journal:  Int J Nanomedicine       Date:  2014-02-11

6.  Assessment of the Anticonvulsant Potency of Ursolic Acid in Seizure Threshold Tests in Mice.

Authors:  Dorota Nieoczym; Katarzyna Socała; Piotr Wlaź
Journal:  Neurochem Res       Date:  2018-03-14       Impact factor: 3.996

Review 7.  Ursolic acid in health and disease.

Authors:  Dae Yun Seo; Sung Ryul Lee; Jun-Won Heo; Mi-Hyun No; Byoung Doo Rhee; Kyung Soo Ko; Hyo-Bum Kwak; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2018-04-25       Impact factor: 2.016

8.  Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice.

Authors:  Fatemeh Honarvar; Vida Hojati; Nuredin Bakhtiari; Gholamhassan Vaezi; Mohammad Javan
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.